TGFB1 and prostate carcinoma: Consistent with this hypothesis, a recent study in prostate cancer cells demonstrated a reduction in hnRNP E1 protein upon TGFβ treatment, which was reported to be due to hnRNP E1 ubiquitination and subsequent degradation [36].